Nohla Therapeutics Is A Biotechnology Company Based In Seattlewathat Specializes In Developing Universaloff The Shelf Cell Therapiesthe Company Aims To Create Innovative Treatments For Patients With Hematologic Malignancies And Other Critical Diseasestheir Primary Product Is A Universal Donor Cell Therapy Platform That Targets Hematopoietic Recovery And Chemotherapy Induced Neutropeniautilizing Umbilical Cord Blood Expansion Technology Developed At The Fred Hutchinson Cancer Research Center One Of Their Key Offerings Is Dilanubicelnla101 An Off The Shelf Cell Therapy That Has Demonstrated Promising Long Term Survival Outcomes In Clinical Studiesnohla Therapeutics Is Actively Engaged In Clinical Trials And Research Collaborationswith Therapies Currently In Phase 2 Trialsthe Company Collaborates With Research Institutions And Manufacturing Partners To Ensure The Effective Production And Distribution Of Its Therapiesfocusing On Expanding The Applications Of Its Cell Therapies To Address A Wider Range Of Critical Diseases
No conferences found for this company.
| Company Name | Nohla Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
